Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
May 10, 2021 11:25 ET
|
ALK Abello
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
May 10, 2021 11:25 ET
|
ALK Abello
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af...
Three-month interim report (Q1) 2021
May 05, 2021 00:57 ET
|
ALK Abello
ALK reports 9% sales growth in Q1 fuelled by better than expected tablet growth of 32% (unaudited) The first three months of 2021 represented ALK’s best-ever quarter, with revenue exceeding DKK 1...
Three-month interim report (Q1) 2021
May 05, 2021 00:57 ET
|
ALK Abello
Bemærk venligst, at rapporten foreligger udelukkende på engelsk. ALK reports 9% sales growth in Q1 fuelled by better than expected tablet growth of 32% (unaudited) The first three months of 2021...
Release date of three-month interim report (Q1) 2021 for ALK and audio cast
April 28, 2021 03:08 ET
|
ALK Abello
On Wednesday, 5 May 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its three-month interim report (Q1) 2021. ALK will host a meeting for analysts and institutional investors that day at...
Dato for offentliggørelse af delårsrapport for første kvartal 2021 for ALK og webcast
April 28, 2021 03:08 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første kvartal 2021 onsdag den 5. maj 2021. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og...
ALK gains paediatric approval for its ragweed SLIT-tablet in the USA
April 19, 2021 05:40 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The US Food and Drug Administration has approved extending the current product labelling of RAGWITEK® to include paediatric allergic rhinitis patientsThe...
Grant of share options and performance shares to members of the Board of Management and key employees
March 26, 2021 08:00 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Share option programmeAccording to the Company’s remuneration policy which was once again adopted at the Company's annual general meeting on 18 March...
Tildeling af aktieoptioner og performance-aktier til direktion og ledende medarbejdere
March 26, 2021 08:00 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): AktieoptionsprogramBestyrelsen har i overensstemmelse med Selskabets vederlagspolitik, som blev vedtaget på Selskabets generalforsamling den 18. marts...
Annual General Meeting in ALK-Abelló A/S held on 18 March 2021
March 18, 2021 12:42 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 18 March 2021. The Annual General Meeting transacted the following business: Adoption of the annual...